According to the new market research report “Viral Clearance Market by Application (Recombinant Proteins, Blood, Vaccines), End User (Pharmaceutical & Biotechnology Companies, CROs), Method (Viral Removal (Chromatography, Nanofiltration), Viral Inactivation (Low pH)) - Global Forecast”, published by MarketsandMarkets™.
Revenue Growth of the Market:
The Global Viral Clearance Market is expected to reach $724.5 million by 2023 from USD 271.2 million in 2018, at a CAGR of 21.7% during the forecast period.
Market Segmentation:-
On the basis of application, the global market is segmented into four categories recombinant proteins, blood and blood products, vaccines, and other applications. In 2018, the recombinant proteins segment is expected to account for the largest share of the viral clearance market owing to the high potential of recombinant proteins to treat various diseases, fewer side effects, and shorter development time as compared to small molecules.
On the basis of the method, the viral clearance market is segmented into viral removal and viral inactivation. In 2018, the viral removal segment is expected to account for the largest share of the global market due to the growth in the biopharmaceutical R&D activities; the high acceptance of this method; and the accuracy, speed, and flexibility provided by the method in life sciences research
Download PDF (Please provide your specific interest in this report so as to help you better.):
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=62681197
Market Growth Drivers:
- Growth in the Pharmaceutical and Biotechnology Industries
- Increasing Number of Drug Launches
- High Incidence and Large Economic Burden of Chronic Diseases
- Possibility of Cell Culture Contamination
- Advancements in Nanofiltration Technology
Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=62681197
Geographical Analysis:
The North American region is expected to account for the largest share of the market in 2018.
However, Asia Pacific is expected to witness the highest growth during the forecast period, owing to increase in generics development and manufacturing, surge in funding for medical research and the presence of a large number of CROs to provide preclinical and clinical research services in China, government initiatives to boost the use of generic drugs, increasing aging population in Japan, rise in pharmaceutical R&D expenditures in India, and the growing pharmaceutical manufacturing in Singapore and Malaysia.
Major Key Players In Global Viral Clearance Market:
Wuxi Biologics (Cayman) (China), Merck KGaA (Germany), Charles River Laboratories International Inc. (US), and Texcell Inc. (France), Kedrion (Italy), Vironova Biosafety (Sweden), Clean Cells (France), BSL BIOSERVICE Scientific Laboratories Munich GmbH (Germany), and ViruSure GmbH (Austria).
The report “Viral Clearance Market by Application (Recombinant Proteins, Blood, Vaccines), End User (Pharmaceutical & Biotechnology Companies, CROs), Method (Viral Removal (Chromatography, Nanofiltration), Viral Inactivation (Low pH)) – Global Forecasts to 2023″, is expected to reach USD 724.5 million by 2023 from USD 271.2 million in 2018, at a CAGR of 21.7%.The growth of Viral Clearance Market is primarily driven by factors such as the growth in the pharmaceutical and biotechnology industries, increasing number of new drug launches, R investments in life science, advancements in nanofiltration technology, and high incidence and large economic burden of chronic diseases.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=62681197Based on application, segmented into recombinant proteins, blood and blood products, vaccines, and other applications.
The other applications segment is expected to grow at the highest CAGR during the forecast owing to the increasing use of cellular therapies in the treatment of various disorders, increasing public and private funding for stem cell research, rising awareness about stem cell therapies, and the use of tissue-based therapies to treat various diseases.Geographical View in-detailed:The North American region is expected to account for the largest share of the market in 2018.
In Canada, increasing pharmaceutical production is expected to boost the growth of the viral clearance market.However, Asia Pacific is expected to witness the highest growth during the forecast period, owing to increase in generics development and manufacturing, surge in funding for medical research and the presence of a large number of CROs to provide preclinical and clinical research services in China, government initiatives to boost the use of generic drugs, increasing aging population in Japan, rise in pharmaceutical R expenditures in India, and the growing pharmaceutical manufacturing in Singapore and Malaysia.Global Key Leaders:The key players in the global viral clearance market are Wuxi Biologics (Cayman) (China), Merck KGaA (Germany), Charles River Laboratories International Inc. (US), and Texcell Inc. (France), Kedrion (Italy), Vironova Biosafety (Sweden), Clean Cells (France), BSL BIOSERVICE Scientific Laboratories Munich GmbH (Germany), and ViruSure GmbH (Austria).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=62681197Wuxi Biologics (Cayman) (China) dominated the global viral clearance market in 2017.
The company’s revenue increased from USD 148.9 million in 2016 to USD 239.6 in 2017; this has helped the company reinforce its position in the market.
Wuxi maintains 12 viral clearance suites to cater to the growing customer needs worldwide.
Additionally, the company has a comprehensive database mining strategy to design optimal process parameters and steps for viral clearance to avoid ineffective steps.
The Global Viral Clearance Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The report offers a value chain analysis that gives a comprehensive outlook of the viral clearance market.
The attractiveness analysis of this market has also been included so as to evaluate the segments that are anticipated to be profitable during the forecast period.Browse the complete Global Viral Clearance Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/7657-viral-clearance-market-reportThe report also covers the complete competitive landscape of the global Viral Clearance market with company profiles of key players such as:Avance Biosciences Inc.BSL BioserviceCharles River Laboratories International, Inc.Clean Cells Inc.Lonza GroupMerck KGAASGS S.A.Sigma-Aldrich CorporationTexcell, Inc.Wuxi Pharmatech (Cayman) Inc.A detailed description of each has been included, with information in terms of headquarters, inception, stock listing, upcoming capacities, key mergers & acquisitions, financial overview, and recent developments.
This analysis gives a thorough idea about the competitive positioning of market players.
The report also gives information of viral clearance market’s mergers/acquisitions, partnerships, collaborations, new product launches, new product developments and other industry developments.SEGMENTATIONS IN REPORT:Viral Clearance Market Analysis by Application:Vaccines And TherapeuticsBlood And Blood ProductsCellular And Gene Therapy ProductsTissue And Tissue ProductsStem Cell ProductsViral Clearance Market Analysis by Method:Viral Detection MethodViral RemovalViral InactivationViral Clearance Market Analysis by End User:Pharmaceutical And Biotechnology CompaniesContract Research OrganizationsAcademic Research InstitutesOther End UsersViral Clearance Market Analysis by Geography:North AmericaEuropeAsia PacificRest of the WorldDownload Free Sample Report of Global Viral Clearance Market @ https://www.decisiondatabases.com/contact/download-sample-7657The Global Viral Clearance Market has been exhibited in detail in the following chapters –Chapter 1 Viral Clearance Market PrefaceChapter 2 Executive SummaryChapter 3 Viral Clearance Industry AnalysisChapter 4 Viral Clearance Market Value Chain AnalysisChapter 5 Viral Clearance Market Analysis By ApplicationChapter 6 Viral Clearance Market Analysis By MethodChapter 7 Viral Clearance Market Analysis By End UserChapter 8 Viral Clearance Market Analysis By GeographyChapter 9 Competitive Landscape Of Viral Clearance CompaniesChapter 10 Company Profiles Of Viral Clearance IndustryPurchase the complete Global Viral Clearance Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-7657Other Reports by DecisionDatabases.com:Global Viral Inactivation Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Antiviral Drugs Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
Viral contamination can affect cell culture processes, raw materials, bioreactor contamination and downstream processing which in turn creates demand for viral safety practice along with implementation of virus clearance process into the manufacturing process.
Rising number of new drug launches is the vital factor escalating the market growth, also rising favorable research and development investment scenario, increasing possibility of cell culture contamination, increase in the advancements in nanofiltration technology and rise in the incidence and large economic burden of chronic diseases are the major factors among others driving the viral clearance market.
Moreover, rising pharmaceutical outsourcing and rise in the emerging markets will further create new opportunities for viral clearance market in the forecasted period of 2021-2028.However, increase in the cost and time-intensive drug development process and increased degree of consolidation act are the major factors among others which will obstruct the market growth, while increase in the dearth of skilled professionals will further challenge the growth of viral clearance market in the forecast period mentioned above.Viral clearance market is expected to gain market growth in the forecast period of 2021 to 2028.
Data Bridge Market Research analyses the market to grow at a CAGR of 21.45% in the above-mentioned forecast period.
Rising growth in the pharmaceutical and biotechnology industries drives the viral clearance market.This Global Viral Clearance Market research report intensely analyses the potential of the market with respect to current scenario and the future prospects by considering several industry aspects of Cardinal Health industry.
This Global Viral Clearance Market report provides major statistics on the market status of global and regional manufacturers and is a helpful source of assistance and direction for companies and individuals interested in Healthcare industry.
